{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:29:38Z","timestamp":1790634578771,"version":"4.1.0"},"reference-count":114,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2014,11,5]],"date-time":"2014-11-05T00:00:00Z","timestamp":1415145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"NIH Program Project","award":["P01CA148600"],"award-info":[{"award-number":["P01CA148600"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Allogeneic hematopoietic stem cell transplantation is an important treatment option for fit patients with poor-risk hematological malignancies; nevertheless, the lack of available fully matched donors limits the extent of its use. Umbilical cord blood has emerged as an effective alternate source of hematopoietic stem cell support. Transplantation with cord blood allows for faster availability of frozen sample and avoids invasive procedures for donors. In addition, this procedure has demonstrated reduced relapse rates and similar overall survival when compared with unrelated allogeneic hematopoietic stem cell transplantation. The limited dose of CD34-positive stem cells available with single-unit cord transplantation has been addressed by the development of double-unit cord transplantation. In combination with improved conditioning regimens, double-unit cord transplantation has allowed for the treatment of larger children, as well as adult patients with hematological malignancies. Current excitement in the field revolves around the development of safer techniques to improve homing, engraftment, and immune reconstitution after cord blood transplantation. Here the authors review the past, present, and future of cord transplantation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5966\/sctm.2014-0151","type":"journal-article","created":{"date-parts":[[2014,11,7]],"date-time":"2014-11-07T02:35:16Z","timestamp":1415327716000},"page":"1435-1443","source":"Crossref","is-referenced-by-count":83,"title":["Concise Review: Umbilical Cord Blood Transplantation: Past, Present, and Future"],"prefix":"10.1093","volume":"3","author":[{"given":"Javier","family":"Munoz","sequence":"first","affiliation":[{"name":"Department of Hematology-Oncology, Banner MD Anderson Cancer Center, Gilbert, Arizona, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katayoun","family":"Rezvani","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitra","family":"Hosing","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Bollard","sequence":"additional","affiliation":[{"name":"Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Hospital System, George Washington University, Washington, D.C., USA"},{"name":"Department of Pediatrics, George Washington University, Washington, D.C., USA"},{"name":"Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, D.C., USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betul","family":"Oran","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Olson","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday","family":"Popat","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Molldrem","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian K.","family":"McNiece","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Shpall","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,11,5]]},"reference":[{"issue":"suppl","key":"2021122709525419300_R1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bbmt.2008.05.017","article-title":"The national marrow donor program 20 years of unrelated donor hematopoietic cell transplantation","volume":"14","author":"Ballen","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"2021122709525419300_R2","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.bbmt.2010.08.011","article-title":"Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities","volume":"16","author":"Barker","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"2021122709525419300_R3","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1073\/pnas.86.10.3828","article-title":"Human umbilical cord blood as a potential source of transplantable hematopoietic stem\/progenitor cells","volume":"86","author":"Broxmeyer","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122709525419300_R4","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1056\/NEJM198910263211707","article-title":"Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling","volume":"321","author":"Gluckman","year":"1989","journal-title":"N Engl J Med"},{"key":"2021122709525419300_R5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood.V88.3.795.795","article-title":"Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: Analysis of engraftment and acute graft-versus-host disease","volume":"88","author":"Wagner","year":"1996","journal-title":"Blood"},{"key":"2021122709525419300_R6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM199607183350303","article-title":"Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients","volume":"335","author":"Kurtzberg","year":"1996","journal-title":"N Engl J Med"},{"key":"2021122709525419300_R7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/bbmt.2002.v8.pm12064362","article-title":"Searching for unrelated donor hematopoietic stem cells: Availability and speed of umbilical cord blood versus bone marrow","volume":"8","author":"Barker","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"issue":"suppl 1","key":"2021122709525419300_R8","first-page":"S17","article-title":"NETCORD: A cord blood allocation network","volume":"22","author":"Hakenberg","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"2021122709525419300_R9","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1182\/blood.V92.10.3515","article-title":"Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient","volume":"92","author":"Petersdorf","year":"1998","journal-title":"Blood"},{"key":"2021122709525419300_R10","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1182\/blood.V91.1.340","article-title":"The umbilical cord blood alphabeta T-cell repertoire: Characteristics of a polyclonal and naive but completely formed repertoire","volume":"91","author":"Garderet","year":"1998","journal-title":"Blood"},{"key":"2021122709525419300_R11","first-page":"3662","article-title":"Factors associated with outcome after cord blood transplantation in children with acute leukemia","volume":"93","author":"Locatelli","year":"1999","journal-title":"Blood"},{"key":"2021122709525419300_R12","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.1182\/blood-2003-04-1288","article-title":"Unrelated cord blood transplantation for childhood acute myeloid leukemia: A Eurocord Group analysis","volume":"102","author":"Michel","year":"2003","journal-title":"Blood"},{"key":"2021122709525419300_R13","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1182\/blood-2007-06-098020","article-title":"Results of the Cord Blood Transplantation Study (COBLT): Clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies","volume":"112","author":"Kurtzberg","year":"2008","journal-title":"Blood"},{"key":"2021122709525419300_R14","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/S0140-6736(07)60915-5","article-title":"Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: A comparison study","volume":"369","author":"Eapen","year":"2007","journal-title":"Lancet"},{"key":"2021122709525419300_R15","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1182\/blood-2011-06-363572","article-title":"Transplantation in patients with SCID: Mismatched related stem cells or unrelated cord blood?","volume":"119","author":"Fernandes","year":"2012","journal-title":"Blood"},{"key":"2021122709525419300_R16","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.bbmt.2012.01.019","article-title":"Unrelated donor cord blood transplantation for children with severe sickle cell disease: Results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)","volume":"18","author":"Kamani","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"2021122709525419300_R17","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1056\/NEJMoa042604","article-title":"Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease","volume":"352","author":"Escolar","year":"2005","journal-title":"N Engl J Med"},{"key":"2021122709525419300_R18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/sj.bmt.1703863","article-title":"Successful umbilical cord blood stem cell transplantation for chronic granulomatous disease","volume":"31","author":"Bhattacharya","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"2021122709525419300_R19","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1056\/NEJMoa032613","article-title":"Cord-blood transplants from unrelated donors in patients with Hurler's syndrome","volume":"350","author":"Staba","year":"2004","journal-title":"N Engl J Med"},{"key":"2021122709525419300_R20","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1182\/blood-2012-09-455238","article-title":"Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning","volume":"121","author":"Boelens","year":"2013","journal-title":"Blood"},{"key":"2021122709525419300_R21","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199811263392201","article-title":"Outcomes among 562 recipients of placental-blood transplants from unrelated donors","volume":"339","author":"Rubinstein","year":"1998","journal-title":"N Engl J Med"},{"key":"2021122709525419300_R22","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1056\/NEJM200106143442402","article-title":"Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors","volume":"344","author":"Laughlin","year":"2001","journal-title":"N Engl J Med"},{"key":"2021122709525419300_R23","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1056\/NEJMoa041469","article-title":"Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia","volume":"351","author":"Rocha","year":"2004","journal-title":"N Engl J Med"},{"key":"2021122709525419300_R24","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1056\/NEJMoa041276","article-title":"Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia","volume":"351","author":"Laughlin","year":"2004","journal-title":"N Engl J Med"},{"key":"2021122709525419300_R25","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1470-2045(10)70127-3","article-title":"Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: A retrospective analysis","volume":"11","author":"Eapen","year":"2010","journal-title":"Lancet Oncol"},{"key":"2021122709525419300_R26","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1182\/blood-2004-07-2717","article-title":"Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy","volume":"105","author":"Barker","year":"2005","journal-title":"Blood"},{"key":"2021122709525419300_R27","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/bmt.2011.184","article-title":"Factors predicting single-unit predominance after double umbilical cord blood transplantation","volume":"47","author":"Ramirez","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"2021122709525419300_R28","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1182\/blood-2009-07-228999","article-title":"Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit","volume":"115","author":"Gutman","year":"2010","journal-title":"Blood"},{"key":"2021122709525419300_R29","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/blood-2008-07-163238","article-title":"Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: Analysis of risk factors","volume":"113","author":"MacMillan","year":"2009","journal-title":"Blood"},{"key":"2021122709525419300_R30","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1200\/JCO.2007.15.8865","article-title":"Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: A study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation","volume":"27","author":"Rodrigues","year":"2009","journal-title":"J Clin Oncol"},{"key":"2021122709525419300_R31","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/bmt.2011.195","article-title":"Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies","volume":"47","author":"Kindwall-Keller","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"2021122709525419300_R32","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/blood-2010-05-285304","article-title":"Allogeneic hematopoietic cell transplantation for hematologic malignancy: Relative risks and benefits of double umbilical cord blood","volume":"116","author":"Brunstein","year":"2010","journal-title":"Blood"},{"key":"2021122709525419300_R33","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1182\/blood-2002-11-3337","article-title":"Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning","volume":"102","author":"Barker","year":"2003","journal-title":"Blood"},{"key":"2021122709525419300_R34","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bbmt.2006.08.041","article-title":"Double unrelated reduced-intensity umbilical cord blood transplantation in adults","volume":"13","author":"Ballen","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"2021122709525419300_R35","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1182\/blood-2011-12-400630","article-title":"Reduced-intensity conditioning transplantation in acute leukemia: The effect of source of unrelated donor stem cells on outcomes","volume":"119","author":"Brunstein","year":"2012","journal-title":"Blood"},{"key":"2021122709525419300_R36","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/blood-2011-03-344853","article-title":"Alternative donor transplantation after reduced intensity conditioning: Results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts","volume":"118","author":"Brunstein","year":"2011","journal-title":"Blood"},{"key":"2021122709525419300_R37"},{"key":"2021122709525419300_R38"},{"key":"2021122709525419300_R39"},{"key":"2021122709525419300_R40"},{"key":"2021122709525419300_R41"},{"key":"2021122709525419300_R42"},{"key":"2021122709525419300_R43"},{"issue":"suppl","key":"2021122709525419300_R44","doi-asserted-by":"crossref","first-page":"S247","DOI":"10.1016\/j.bbmt.2013.12.414","article-title":"Double unit umbilical cord blood transplant for adults with acute leukemia and myelodysplastic syndrome results in comparable outcome as matched sibling or unrelated donor transplant only after myeloablative conditioning but not reduced intensity conditio","volume":"20","author":"Poon","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"suppl","key":"2021122709525419300_R45","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1016\/j.bbmt.2013.12.378","article-title":"Characteristics and outcome of cytomegalovirus (CMV) infections in 95 cord blood transplant (CBT) recipients: The MD Anderson experience","volume":"20","author":"Ghantoji","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"suppl","key":"2021122709525419300_R46","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1016\/j.bbmt.2013.12.212","article-title":"Double-unit cord blood (CB) transplantation combined with haplo-identical CD34+ cells results in 100% CB engraftment with enhanced myeloid CD34+ recovery","volume":"20","author":"Barker","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"suppl","key":"2021122709525419300_R47","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1016\/j.bbmt.2013.12.219","article-title":"Outcomes of double unit umbilical cord blood transplantation using fludarabine\/busulfan based reduced intensity conditioning regimen","volume":"20","author":"Volodin","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"suppl","key":"2021122709525419300_R48","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.bbmt.2013.12.065","article-title":"High disease-free survival and enhanced protection against relapse after double-unit cord blood transplantation (DCB-T) when compared to unrelated donor transplantation (URD-T) in patients with acute leukemia, MDS and CML","volume":"20","author":"Ponce","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"2021122709525419300_R49"},{"key":"2021122709525419300_R50","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1056\/NEJMp078166","article-title":"Hematopoietic-cell transplantation at 50","volume":"357","author":"Appelbaum","year":"2007","journal-title":"N Engl J Med"},{"key":"2021122709525419300_R51","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/asheducation.V2012.1.215.3798291","article-title":"Umbilical cord blood transplantation: A maturing technology","volume":"2012","author":"Oran","year":"2012","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"2021122709525419300_R52","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.bmt.1705979","article-title":"Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: A phase I\/II clinical trial","volume":"41","author":"de Lima","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"2021122709525419300_R53","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nm.2080","article-title":"Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution","volume":"16","author":"Delaney","year":"2010","journal-title":"Nat Med"},{"key":"2021122709525419300_R54","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/sj.bmt.1705258","article-title":"Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells","volume":"37","author":"Robinson","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"2021122709525419300_R55","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/bmt.2009.284","article-title":"Ex vivo expansion of cord blood","volume":"44","author":"Kelly","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"2021122709525419300_R56","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1207285","article-title":"Cord-blood engraftment with ex vivo mesenchymal-cell coculture","volume":"367","author":"de Lima","year":"2012","journal-title":"N Engl J Med"},{"key":"2021122709525419300_R57","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S1470-2045(08)70180-3","article-title":"Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: A phase I\/II study","volume":"9","author":"Frassoni","year":"2008","journal-title":"Lancet Oncol"},{"key":"2021122709525419300_R58","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/bmt.2008.329","article-title":"Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor","volume":"43","author":"Bautista","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"2021122709525419300_R59","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0301-472X(03)00067-5","article-title":"Unrelated umbilical cord blood transplants in adults: Early recovery of neutrophils by supportive co-transplantation of a low number of highly purified peripheral blood CD34+ cells from an HLA-haploidentical donor","volume":"31","author":"Fern\u00e1ndez","year":"2003","journal-title":"Exp Hematol"},{"key":"2021122709525419300_R60","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1182\/blood-2004-02-0650","article-title":"Surface fucosylation of human cord blood cells augments binding to P-selectin and E-selectin and enhances engraftment in bone marrow","volume":"104","author":"Xia","year":"2004","journal-title":"Blood"},{"key":"2021122709525419300_R61","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.exphem.2012.01.015","article-title":"Ex vivo fucosylation improves human cord blood engraftment in NOD-SCID IL-2R\u03b3(null) mice","volume":"40","author":"Robinson","year":"2012","journal-title":"Exp Hematol"},{"key":"2021122709525419300_R62","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1182\/blood-2009-01-201335","article-title":"Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation","volume":"113","author":"Hoggatt","year":"2009","journal-title":"Blood"},{"key":"2021122709525419300_R63","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1182\/blood-2013-05-503177","article-title":"Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation","volume":"122","author":"Cutler","year":"2013","journal-title":"Blood"},{"key":"2021122709525419300_R64","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2010-07-293795","article-title":"Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: Safety profile and detection kinetics","volume":"117","author":"Brunstein","year":"2011","journal-title":"Blood"},{"key":"2021122709525419300_R65","doi-asserted-by":"crossref","first-page":"e76781","DOI":"10.1371\/journal.pone.0076781","article-title":"Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity","volume":"8","author":"Shah","year":"2013","journal-title":"PLoS One"},{"key":"2021122709525419300_R66","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1182\/blood-2009-03-213256","article-title":"Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes","volume":"114","author":"Hanley","year":"2009","journal-title":"Blood"},{"key":"2021122709525419300_R67","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3109\/10428194.2012.739688","article-title":"Immune reconstitution after combined haploidentical and umbilical cord blood transplant","volume":"54","author":"Jain","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"2021122709525419300_R68"},{"key":"2021122709525419300_R69","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2141.2011.08598.x","article-title":"Milestones in umbilical cord blood transplantation","volume":"154","author":"Gluckman","year":"2011","journal-title":"Br J Haematol"},{"key":"2021122709525419300_R70","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/08998280.2011.11928697","article-title":"The origins of bone marrow as the seedbed of our blood: From antiquity to the time of Osler","volume":"24","author":"Cooper","year":"2011","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"2021122709525419300_R71","doi-asserted-by":"crossref","first-page":"357","DOI":"10.7326\/0003-4819-13-2-357","article-title":"Aplastic anemia treated with daily transfusions and intravenous marrow: Case report","volume":"13","author":"Osgood","year":"1939","journal-title":"Ann Intern Med"},{"key":"2021122709525419300_R72","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1182\/blood.V12.8.746.746","article-title":"Experimental treatment of total-body irradiation injury: A brief review","volume":"12","author":"Congdon","year":"1957","journal-title":"Blood"},{"key":"2021122709525419300_R73","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1172\/JCI103949","article-title":"Supralethal whole body irradiation and isologous marrow transplantation in man","volume":"38","author":"Thomas","year":"1959","journal-title":"J Clin Invest"},{"key":"2021122709525419300_R74","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJM195709122571102","article-title":"Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy","volume":"257","author":"Thomas","year":"1957","journal-title":"N Engl J Med"},{"key":"2021122709525419300_R75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V14.1.1.1","article-title":"Irradiation of the entire body and marrow transplantation: Some observations and comments","volume":"14","author":"Thomas","year":"1959","journal-title":"Blood"},{"key":"2021122709525419300_R76","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1056\/NEJM197504172921605","article-title":"Bone-marrow transplantation (first of two parts)","volume":"292","author":"Thomas","year":"1975","journal-title":"N Engl J Med"},{"key":"2021122709525419300_R77","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0140-6736(68)92673-1","article-title":"Immunological reconstitution of sex-linked lymphopenic immunological deficiency","volume":"2","author":"Gatti","year":"1968","journal-title":"Lancet"},{"key":"2021122709525419300_R78","first-page":"349","article-title":"Bone-marrow transplantation following combination chemotherapy immunosuppression (B.A.C.T.) in patients with acute leukemia","volume":"6","author":"Graw","year":"1974","journal-title":"Transplant Proc"},{"key":"2021122709525419300_R79","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1182\/blood.V45.2.171.171","article-title":"Long-term remission from acute myelogenous leukemia after bone marrow transplantation and recovery from acute graft-versus-host reaction and prolonged immunoincompetence","volume":"45","author":"Bleyer","year":"1975","journal-title":"Blood"},{"key":"2021122709525419300_R80","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1182\/blood.V52.1.85.85","article-title":"Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma","volume":"52","author":"Appelbaum","year":"1978","journal-title":"Blood"},{"key":"2021122709525419300_R81","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-3083.1994.tb03382.x","article-title":"The Nobel Lectures in Immunology: The Nobel Prize for Physiology or Medicine, 1990. Bone marrow transplantation: Past, present and future","volume":"39","author":"Thomas","year":"1994","journal-title":"Scand J Immunol"},{"key":"2021122709525419300_R82","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1056\/NEJM199607183350304","article-title":"Cord-blood transplantation from an unrelated donor in an adult with chronic myelogenous leukemia","volume":"335","author":"Laporte","year":"1996","journal-title":"N Engl J Med"},{"key":"2021122709525419300_R83","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJM199708073370602","article-title":"Outcome of cord-blood transplantation from related and unrelated donors","volume":"337","author":"Gluckman","year":"1997","journal-title":"N Engl J Med"},{"key":"2021122709525419300_R84","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJM200006223422501","article-title":"Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling","volume":"342","author":"Rocha","year":"2000","journal-title":"N Engl J Med"},{"key":"2021122709525419300_R85","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1182\/blood.V90.12.4665","article-title":"Placental and\/or umbilical cord blood: An alternative source of hematopoietic stem cells for transplantation","volume":"90","author":"Cairo","year":"1997","journal-title":"Blood"},{"key":"2021122709525419300_R86","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1182\/blood.V98.8.2332","article-title":"Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies","volume":"98","author":"Sanz","year":"2001","journal-title":"Blood"},{"key":"2021122709525419300_R87","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/bbmt.2002.v8.pm12171483","article-title":"Transplantation of ex vivo expanded cord blood","volume":"8","author":"Shpall","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"2021122709525419300_R88","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1084\/jem.20040440","article-title":"A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential","volume":"200","author":"K\u00f6gler","year":"2004","journal-title":"J Exp Med"},{"key":"2021122709525419300_R89","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood-2007-04-067215","article-title":"Umbilical cord blood transplantation after nonmyeloablative conditioning: Impact on transplantation outcomes in 110 adults with hematologic disease","volume":"110","author":"Brunstein","year":"2007","journal-title":"Blood"},{"key":"2021122709525419300_R90","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.beha.2010.07.005","article-title":"Double cord blood transplantation: Extending the use of unrelated umbilical cord blood cells for patients with hematological diseases","volume":"23","author":"Rocha","year":"2010","journal-title":"Best Pract Res Clin Haematol"},{"key":"2021122709525419300_R91","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jcyt.2013.07.003","article-title":"Fucosylation with fucosyltransferase VI or fucosyltransferase VII improves cord blood engraftment","volume":"16","author":"Robinson","year":"2014","journal-title":"Cytotherapy"},{"key":"2021122709525419300_R92","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/10428199309087003","article-title":"Long-term generation of colony-forming cells (CFC) from CD34+ human umbilical cord blood cells","volume":"11","author":"Durand","year":"1993","journal-title":"Leuk Lymphoma"},{"key":"2021122709525419300_R93","first-page":"73","article-title":"Ex vivo expansion of hematopoietic progenitor cells in human cord blood: An effect enhanced by cord blood serum","volume":"9","author":"Kurata","year":"1995","journal-title":"Hematol Pathol"},{"key":"2021122709525419300_R94","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1365-2141.1995.tb05219.x","article-title":"The effect of interleukin-12 in ex-vivo expansion of human haemopoietic progenitors","volume":"90","author":"Bertolini","year":"1995","journal-title":"Br J Haematol"},{"key":"2021122709525419300_R95","first-page":"1463","article-title":"Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy","volume":"23","author":"Siena","year":"1995","journal-title":"Exp Hematol"},{"key":"2021122709525419300_R96","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1182\/blood.V87.4.1261.bloodjournal8741261","article-title":"Hematopoietic potential of cryopreserved and ex vivo manipulated umbilical cord blood progenitor cells evaluated in vitro and in vivo","volume":"87","author":"DiGiusto","year":"1996","journal-title":"Blood"},{"key":"2021122709525419300_R97","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1182\/blood.V89.3.1089","article-title":"A murine model for human cord blood transplantation: Near-term fetal and neonatal peripheral blood cells can achieve long-term bone marrow engraftment in sublethally irradiated adult recipients","volume":"89","author":"Scaradavou","year":"1997","journal-title":"Blood"},{"key":"2021122709525419300_R98","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/sj.leu.2400588","article-title":"Thrombopoietin augments ex vivo expansion of human cord blood-derived hematopoietic progenitors in combination with stem cell factor and flt3 ligand","volume":"11","author":"Ohmizono","year":"1997","journal-title":"Leukemia"},{"key":"2021122709525419300_R99","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/scd.1.1997.6.93","article-title":"Ex vivo expansion of CD34 + CD38- cord blood cells","volume":"6","author":"De Bruyn","year":"1997","journal-title":"J Hematother"},{"key":"2021122709525419300_R100","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1182\/blood.V89.8.2644","article-title":"Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood","volume":"89","author":"Piacibello","year":"1997","journal-title":"Blood"},{"key":"2021122709525419300_R101","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/sj.bmt.1701088","article-title":"The effect of different thawing methods, growth factor combinations and media on the ex vivo expansion of umbilical cord blood primitive and committed progenitors","volume":"21","author":"K\u00f6gler","year":"1998","journal-title":"Bone Marrow Transplant"},{"issue":"suppl 3","key":"2021122709525419300_R102","first-page":"S48","article-title":"An eight-fold ex vivo expansion of long-term culture-initiating cells from umbilical cord blood in stirred suspension cultures","volume":"21","author":"K\u00f6gler","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"2021122709525419300_R103","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/stem.170019","article-title":"Defining optimum conditions for the ex vivo expansion of human umbilical cord blood cells. Influences of progenitor enrichment, interference with feeder layers, early-acting cytokines and agitation of culture vessels","volume":"17","author":"K\u00f6hler","year":"1999","journal-title":"Stem Cells"},{"key":"2021122709525419300_R104","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1182\/blood.V94.12.4053","article-title":"Ex vivo generation of CD34(+) cells from CD34(\u2212) hematopoietic cells","volume":"94","author":"Nakamura","year":"1999","journal-title":"Blood"},{"key":"2021122709525419300_R105","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0301-472X(00)00520-8","article-title":"Increased expansion and differentiation of cord blood products using a two-step expansion culture","volume":"28","author":"McNiece","year":"2000","journal-title":"Exp Hematol"},{"key":"2021122709525419300_R106","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1182\/blood.V97.11.3441","article-title":"Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system","volume":"97","author":"Lewis","year":"2001","journal-title":"Blood"},{"key":"2021122709525419300_R107","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/sj.bmt.1702222","article-title":"Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood","volume":"25","author":"Pecora","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"2021122709525419300_R108","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1073\/pnas.0237086100","article-title":"High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years","volume":"100","author":"Broxmeyer","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122709525419300_R109","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1182\/blood-2001-12-0290","article-title":"Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: Results of a phase 1 trial using the AastromReplicell System","volume":"101","author":"Jaroscak","year":"2003","journal-title":"Blood"},{"key":"2021122709525419300_R110","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/14653240410004916","article-title":"Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine","volume":"6","author":"Peled","year":"2004","journal-title":"Cytotherapy"},{"key":"2021122709525419300_R111","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1182\/blood-2005-09-3904","article-title":"Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy","volume":"107","author":"Serrano","year":"2006","journal-title":"Blood"},{"key":"2021122709525419300_R112","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1172\/JCI70313","article-title":"Epigenetic reprogramming induces the expansion of cord blood stem cells","volume":"124","author":"Chaurasia","year":"2014","journal-title":"J Clin Invest"},{"key":"2021122709525419300_R113","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000345690","article-title":"Impact of selection of cord blood units from the United States and swiss registries on the cost of banking operations","volume":"40","author":"Bart","year":"2013","journal-title":"Transfus Med Hemother"},{"issue":"suppl","key":"2021122709525419300_R114","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/j.bbmt.2012.10.015","article-title":"Cord blood graft engineering","volume":"19","author":"Delaney","year":"2013","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.5966%2Fsctm.2014-0151","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.5966%2Fsctm.2014-0151","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/3\/12\/1435\/41893154\/stcltm_3_12_1435.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/3\/12\/1435\/41893154\/stcltm_3_12_1435.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T21:48:49Z","timestamp":1642542529000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/3\/12\/1435-1443\/6389857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,5]]},"references-count":114,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,11,5]]},"published-print":{"date-parts":[[2014,12,1]]}},"URL":"https:\/\/doi.org\/10.5966\/sctm.2014-0151","relation":{},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,12,1]]},"published":{"date-parts":[[2014,11,5]]}}}